Cancer news from the American Cancer Society.
Published on: April 20, 2020
The US Food and Drug Administration (FDA) approved Jelmyto (mitomycin gel) for a type of urothelial cancer, which is a cancer of the lining of the urinary system.
Published on: December 20, 2019
The US Food and Drug Administration (FDA) has approved a new type of drug for certain people with bladder cancer.
Published on: April 16, 2019
The US Food and Drug Administration (FDA) has approved Balversa (erdafitinib) as the first targeted therapy for bladder cancer.
Published on: July 10, 2018
Surgeons at 15 medical centers in the US have compared the outcomes of robotic surgery to traditional open surgery for bladder cancer. The study found outcomes to be similar for both types of surgery.